14th Annual Optimising Clinical Trials Summit: Site Selection, Feasibility and Patient Recruitment

The year 2020 – the year of pandemic, when the clinical trials professionals are trying to carry out large, important international trials in the midst of coronavirus lockdowns. No doubts that the COVID-19 is influencing the whole clinical research industry, but besides this, there are still occurring many other challenging issues in the clinical trials’ world that need our attention.

At the 14th Annual Optimising Clinical Trials Summit will gather the best clinical trials experts from the top pharma companies which will discuss the impact of pandemic on clinical trials, new innovations such as virtual and hybrid clinical trials, real-world evidence, how to deal with the enormous volumes of data, patient centricity and patient-centred protocol, platform trials and many other interesting case studies.

All clinical trials executives are invited to this extraordinary business meeting, where you will be able to network and discuss current challenges. This exclusive clinical trial event will definitely provide you with lessons learned and give you valuable tips shared by senior-level decision-makers. You will also benefit from remarkable networking opportunities due to limited seats of this business meeting. Do not hesitate and book the dates 17-19 November 2020 for this inspiring and high-level clinical trials conference in London!

Join us and register today

Stay on top of the latest trends

Key speakers

Maarten <br><strong>Boomsma</strong>


Clinical Study Director
Marta <br><strong>GARCIA MANRIQUE</strong>


Patient Officer, R&D
Ekkehard <br><strong> Brockstedt</strong>


Head of Team Outsourced Trials, Corp. Div. Medicine
Oleksandr <br> <strong>Gorbenko</strong>


Global Patient Centricity Director
Luigi <br><strong> Petillo</strong>


Clinical Information Science Director
Claus <br><strong>Goebel</strong>


Head Country Clinical Operations Germany & Switzerland

Key topics

  • Platform trials – How to run them successfully?
  • The new era of virtual trials and real-world evidence
  • Shared Investigator Platform (SIP) – A new way of customer-centric study management
  • Clinical trial transparency and patient centricity
  • Patient-centred protocol – What does it look like?
  • Are patient-centricity and regulatory requirements compatible?
  • LEO Innovation Lab – Sharing virtual clinical trial experiences
  • CRO – Is sponsor innovation still feasible in clinical trials?

Who Should Attend

Members of board, C-level, Senior/Global Vice Presidents, Directors, Heads of departments from pharmaceutical industry involved in:

  • Clinical Trials
  • Clinical Development
  • Virtual Trials
  • Hybrid Trials
  • Clinical Operations
  • Clinical Innovation
  • Research & Development
  • Clinical Study

  • Protocol Optimisation
  • Clinical Trial Transparency
  • Study Start-up
  • Data Management
  • Patient Recruitment
  • Site Selection and Feasibility
  • Clinical Regulation
  • Patient Centricity
  • Clinical Site
  • Clinical Project
  • Study Management
  • Clinical Sciences